Antibiotics | Number of studies | Number of MRSA Isolates | Proportion (95% CI) | chi2 | Heterogeneity P | I2 | p |
---|---|---|---|---|---|---|---|
Dalbavancin | 11 | 28539 | 1.00, (1.00,1.00) | 8.22 | 0.61 | 0.00% | 0.00 |
Oritavancin | 2 | 420 | 1.00, (1.00,1.00) | Â | Â | Â | 0.00 |
Tedizolid | 21 | 12204 | 1.00, (1.00,1.00) | 7.57 | 0.99 | 0.00% | 0.00 |
Telavancin | 8 | 7353 | 1.00, (1.00,1.00) | 3.26 | 0.86 | 0.00% | 0.00 |